Evaluation of carotid artery plaque density performed on serial ultrasound scans could help identify patients at high risk for a heart attack or other adverse cardiovascular events, according to Austrian researchers.
Evaluation of carotid artery plaque density performed on serial ultrasound scans could help identify patients at high risk for a heart attack or other adverse cardiovascular events, according to Austrian researchers.
Physicians know that the majority of cardiovascular and cerebrovascular events occur in patients whose blood vessels are less than 70% occluded. Determining the degree of stenosis is thus insufficient to predict a patient's risk of suffering a heart attack or stroke, said lead researcher Dr. Markus Reiter of the department of angiography and interventional radiology at Medical University Vienna.
Reiter's team evaluated the complementary clinical value of computerassisted gray-scale-median (GSM) ultrasound measurements to determine carotid artery plaque density. Previous research has suggested that plaque that appears dark on ultrasound images and has a low GSM level could be unstable and thus associated with an increased risk for clinical complications. Study results strengthened this theory. According to Reiter, patients with reduced GSM levels on follow-up exams showed a significantly increased risk for a near-future adverse event compared with patients with increased GSM levels.
Reiter and colleagues enrolled 1268 asymptomatic patients at high risk of cardiovascular disease who underwent GSM measurement of their carotids. Scans showed that 574 patients had signs of carotid artery disease based on their plaque volume. Each of those patients had a second ultrasound exam six to nine months later to measure plaque changes. GSM levels in 230 of them had decreased at follow-up.
Investigators found that 85 (37%) of those patients experienced a major adverse cardiac event (MACE) such as heart attack, stroke, cardiac surgery, or other intervention within three years of the second ultrasound. In 344 patients, GSM levels increased between the baseline and follow- up exams. Ninety-two (28%) of those patients suffered a MACE. Results showed that vulnerable plaque in the carotid artery was not only an indicator of increased risk of stroke but was associated with disease progression elsewhere in the cardiovascular system.
Results appeared in the September issue of Radiology. Additional studies are needed to validate these findings. In the meantime, however, measuring GSM levels on serial ultrasound scans may be a noninvasive way to identify the presence of vulnerable plaques, according to Reiter.
-By H.A. Abella
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
January 3rd 2025Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.